Determination of the optimal minimum radioiodine dose in patients with Graves' disease: A clinical outcome study

European Journal of Nuclear Medicine

Volumn 28, Issue 10, 2001, Pages 1489-1495

  Howarth, D ^a   Epstein, M ^a   Lan, L ^a   Tan, P ^a   Booker, J ^a  

^a Pacific Medical Imaging   (Australia)

Author keywords

Graves' disease; Hyperthyroidism; Iodine 131; Radioiodine

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; TECHNETIUM 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOSIMETRY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOLOGY; IODINE 131 UPTAKE TEST; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THYROGLOBULIN BLOOD LEVEL; THYROID GLAND; THYROID SCINTISCANNING; TREATMENT OUTCOME; ULTRASOUND;

ADOLESCENT; ADULT; AGED; ALGORITHMS; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SINGLE-BLIND METHOD;

EID: 0034795484     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100621     Document Type: Article

References (28)

1. Radioiodine for hyperthyroidism
2. Treatment of hyperthyroidism with radioactive iodine
3. Levothyroxine therapy in patients with thyroid disease
4. Radioiodine therapy for hyperthyroidism in young patients. Perception of risk and use
5. The standardization of I-131 treatment for hyperthyroidism with an intent to optimize radiation dose and treatment response
6. Optimized dose planning of radioiodine therapy of benign thyroidal diseases
7. The assay for thyroid stimulating immunoglobulin using cultured human thyroid cells
8. Radioiodine therapy of hyperthyroidism
9. Statistics for nuclear medicine. Part 3. A. Comparing two proportions (the relative deviate test and chi-square equivalent). B. Counting data
10. Long-term outcomes of treatment of hyperthyroidism in Ireland
11. Treatment of Graves' hyperthyroidism with radioiodine: Results of a prospective randomized study
12. Low-dose radioiodine given six-monthly in Graves' disease
13. Low dose I-131 in treatment of Graves' disease
14. Long-term follow-up study of compensatedlow-dose I-131 therapy for Graves' disease
15. Rising incidence of hypothyroidism after radioactive iodine therapy for thyrotoxicosis
16. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy
17. Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism
18. Radioiodine is an effective, in-expensive, and safe treatment for Graves' hyperthyroidism, but its immunological effects must be taken into account
19. Radioactive treatment, ablation, and ophthalmopathy: A balanced perspective
20. 131I radioiodine therapy for hyperthyroidism in patients with Graves' disease, uninodular goitre and multinodular goitre
21. Success rate of radioiodine therapy in Graves' disease: The influence of thyrostatic medication
22. Long-term follow-up studies on iodine-131 treatment of hyperthyroid Graves' disease based on the measurement of thyroid volume by ultrasonography
23. Radioiodine-131 treatment of thyrotoxicosis: Dose required for and some factors affecting the early induction of hypothyroidism
24. The results of radioiodine treatment of hyperthyroidism. A preliminary report of the thyrotoxicosis therapy follow-up study
25. Random dosage of I-131 in the treatment of hyperthyroidism: Results of a prospective study
26. Autoantibodies to thyroglobulin in health and disease
27. Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases